Longitudinal hippocampal atrophy in hippocampal sclerosis of aging
- PMID: 37635712
- PMCID: PMC10448324
- DOI: 10.1016/j.nbas.2023.100092
Longitudinal hippocampal atrophy in hippocampal sclerosis of aging
Abstract
Hippocampal sclerosis of aging (HS-A) is a common degenerative neuropathology in older individuals and is associated with dementia. HS-A is characterized by disproportionate hippocampal atrophy at autopsy but cannot be diagnosed during life. Therefore, little is known about the onset and progression of hippocampal atrophy in individuals with HS-A. To better understand the onset and progression of hippocampal atrophy in HS-A, we examined longitudinal hippocampal atrophy using serial MRI in participants with HS-A at autopsy (HS-A+, n = 8) compared to participants with limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) without HS-A (n = 13), Alzheimer's disease neuropathologic change (ADNC) without HS-A or LATE-NC (n = 16), and those without these pathologies (n = 7). We found that participants with HS-A had lower hippocampal volumes compared to the other groups, and this atrophy preceded the onset of dementia. There was also some evidence that rates of hippocampal volume loss were slightly slower in those with HS-A. Together, these results suggest that the disproportionate hippocampal atrophy seen in HS-A may begin early prior to dementia.
Keywords: Alzheimer’s Disease; Dementia; Hippocampal sclerosis of aging; Hippocampus; LATE-NC; MRI.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Common neuropathologic change drivers of hippocampal sclerosis of ageing.Brain. 2025 Jul 7;148(7):2400-2411. doi: 10.1093/brain/awaf158. Brain. 2025. PMID: 40323260 Free PMC article.
-
Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old.Acta Neuropathol. 2023 Sep;146(3):415-432. doi: 10.1007/s00401-023-02606-9. Epub 2023 Jun 29. Acta Neuropathol. 2023. PMID: 37382680 Free PMC article.
-
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.Brain. 2019 Jun 1;142(6):1503-1527. doi: 10.1093/brain/awz099. Brain. 2019. PMID: 31039256 Free PMC article.
-
Pharmacotherapies for sleep disturbances in dementia.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 27851868 Free PMC article. Updated.
-
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2. Cochrane Database Syst Rev. 2021. PMID: 35608903 Free PMC article.
Cited by
-
Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.Acta Neuropathol. 2024 Jun 19;147(1):103. doi: 10.1007/s00401-024-02728-8. Acta Neuropathol. 2024. PMID: 38896163 Free PMC article.
-
In severe ADNC, hippocampi with comorbid LATE-NC and hippocampal sclerosis have substantially more astrocytosis than those with LATE-NC or hippocampal sclerosis alone.J Neuropathol Exp Neurol. 2023 Nov 20;82(12):987-994. doi: 10.1093/jnen/nlad085. J Neuropathol Exp Neurol. 2023. PMID: 37935530 Free PMC article.
-
Evaluating the updated LATE-NC staging criteria using data from NACC.Alzheimers Dement. 2024 Dec;20(12):8359-8373. doi: 10.1002/alz.14262. Epub 2024 Oct 1. Alzheimers Dement. 2024. PMID: 39352226 Free PMC article.
-
New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS.J Neuropathol Exp Neurol. 2025 Jan 1;84(1):2-7. doi: 10.1093/jnen/nlae113. J Neuropathol Exp Neurol. 2025. PMID: 39441698 Review.
-
Common neuropathologic change drivers of hippocampal sclerosis of ageing.Brain. 2025 Jul 7;148(7):2400-2411. doi: 10.1093/brain/awaf158. Brain. 2025. PMID: 40323260 Free PMC article.
References
-
- Montine T.J., Phelps C.H., Beach T.G., Bigio E.H., Cairns N.J., Dickson D.W., et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol (Berl) 2012;123:1–11. doi: 10.1007/s00401-011-0910-3. - DOI - PMC - PubMed